Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03346447
Other study ID # 500-17-06
Secondary ID
Status Completed
Phase N/A
First received September 12, 2017
Last updated January 16, 2018
Start date October 9, 2017
Est. completion date November 13, 2017

Study information

Verified date January 2018
Source Kimberly-Clark Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single-center, prospective, single-blind pilot study to determine baby wipe formulations on an adult dermatitis model.


Description:

This is a single-center, prospective, single-blind pilot study to determine baby wipe formulations on an adult dermatitis model.

Biophysical measurements will be taken at each test sites.


Recruitment information / eligibility

Status Completed
Enrollment 23
Est. completion date November 13, 2017
Est. primary completion date October 27, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- 1. Fluent in English, willing and able to read, understand, and sign the informed consent form (ICF) 2. Ability to complete the course of the study and comply with instructions; 3. Females aged 18 to 40 years, in good general health as deemed by the investigator (no physical required).

4. Caucasian individuals with Fitzpatrick skin type I, II, or III (See Appendix I).

5. Individuals free of any systemic or dermatological disorder including a known history of allergies or other medical conditions which, in the opinion of the investigator, could interfere with the conduct of the study, interpretation of results, or increase the risk of adverse reactions.

6. Anticipated ability to complete the course of the study and to comply with instructions.

7. Females practicing an acceptable method of birth control (abstinence is acceptable). Females of child-bearing potential must have practiced an acceptable method of birth control for the past 3 months and be willing to continue using the same method throughout the duration of the study. Acceptable methods of birth control, include: 1) Systemic birth control (Subjects must have been taking the same type of birth control for at least 3 months prior to entering the study and must not change the type of birth control during the study); 2) Condom with spermicide; 3) IUD; 4) Vasectomized partner; and 5) Abstinence. Females who are post-menopausal (for at least 1 year) or have had a permanent sterilization procedure (i.e. hysterectomy, tubal ligation, bilateral oophorectomy) do not need to have additional birth control methods.

Exclusion Criteria:

- 1. Individuals with any visible skin disease, skin condition (e.g., back acne) including baseline erythema assessment > 0.5, or tattoos in the test area (mid to upper back).

2. Individuals with abnormal skin pigmentation at the test sites, which might interfere with subsequent evaluations of dermal responsiveness.

3. Individuals with recent prolonged sun or tanning bed exposure in the test area 4. Individuals with excessive dryness or redness at the sites of application. 5. Individuals with a known hypersensitivity to any of the components of the insult, controls, or adhesive tapes.

6. Subjects must not have applied any lotions, creams, powders, or oils to their backs the morning of the study. Additionally, two hours must have passed since bathing or showering.

7. Women who are pregnant or nursing. 8. Individuals who have participated on a study involving the test sites (back) in the previous 30 days.

9. Individuals participating in another clinical study 10. Individuals with open or healing cuts/incisions, abrasions, lesions, pustules, fissures, or broken mucosa/skin in the test area

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Artificial Fecal Enzyme
Artificial Fecal enzyme Trypsin/Chymotrypsin mixture

Locations

Country Name City State
United States Reliance Clinical Testing Services Irving Texas

Sponsors (1)

Lead Sponsor Collaborator
Kimberly-Clark Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Erythema Time for a test site to reach an erythema score of = 2. 1 week
Primary Transepidermal Water Loss (TEWL) difference in TEWL between test sites 1 week
Primary pH difference in pH between test sites 1 week
Primary Chromameter redness difference in redness between test sites 1 week
Secondary Biophysical Measurement changes of skin capacitance difference in capacitance between test sites 1 week
Secondary Microbiome profile OTUs of microbiome in test site samples 1 day
See also
  Status Clinical Trial Phase
Completed NCT04544982 - Study to Evaluate the Efficacy of Blue Fenugreek Kale Extract (BFKE) on Skin N/A
Completed NCT05861622 - Examining the Efficacy of a Novel Moisturizer Across Eight Weeks N/A
Active, not recruiting NCT04614753 - Dealcoholized Muscadine Wine and Skin Health in Women N/A
Recruiting NCT06148740 - An Investigation of the Effects of a Skin Serum Containing Propolis on Skin Health and Appearance N/A
Active, not recruiting NCT06148766 - An Investigation of the Effects of a Royal Jelly and Bee Venom-Derived Skin Cream on Skin Health and Signs of Aging N/A
Active, not recruiting NCT06148753 - An Investigation of the Effects of a Royal Jelly and Bee Venom-Derived Skin Serum on Skin Health and Signs of Aging N/A
Completed NCT04511052 - Probiotics for Enhanced Tissue Carotenoid Status in Premenopausal Women Phase 1/Phase 2
Recruiting NCT05925712 - Aerofit Post Market Investigation N/A
Completed NCT02525224 - Nutritional Supplement Efficacy on Cellular Protection and Skin Health in Generally Healthy Adults N/A
Completed NCT04144777 - Efficacy of Solarplast for Health and Oxidative Stress N/A
Recruiting NCT04861623 - Effects of 100% Orange Juice on Skin Health in Women N/A
Completed NCT03771807 - Efficacy of a Nutritional Supplement on Skin Health in Generally Healthy Adults N/A
Recruiting NCT04183920 - To Determine the Activity and Mechanisms of Cranberries to Attenuate Skin Photoaging and Improve Skin Health in Women N/A
Completed NCT06452810 - A Clinical Trial to Evaluate the Effects of a Skin Balm on the Appearance of the Eye Area N/A
Completed NCT00864188 - The Influence of Probiotics in a Drinkable Yogurt on Skin Health Phase 1
Completed NCT03348917 - The Effect of Skin Cleansers on the Skin Surface Microbiome Phase 4
Withdrawn NCT03641430 - The Effects of Over-the-Counter Products on the Skin N/A
Recruiting NCT05128240 - Nutritional Study of Fish Oil in Skin Quality in Healthy Women N/A
Completed NCT00574574 - Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk N/A